11 results
IDSA Suggested Empiric Antibiotic Regimens Based on Clinical Severity for Diabetic Foot Infections
Mild (usually treated with
IDSA Suggested Empiric ... Antibiotic Regimens ... Foot Infections ... #pharmacology # ... idsa #podiatry
IDSA - Diabetic Foot Infections - Suggested Route, Setting, and Duration of Antibiotic Therapy, by Clinical
IDSA - Diabetic ... Foot Infections ... and Duration of Antibiotic ... #Diabetic #Foot ... #pharmacology #
IDSA Recommendations for Preventing and Treating Penicillium marneffei Infections in HIV-AIDS
Preventing 1st Episode of Penicilliosis (Primary
IDSA Recommendations ... 100 cells/mm3 g/mL ... Penicilliosis #IDSA ... #Prevention #Treatment ... infections #HIVAIDS #pharmacology
IDSA Recommendations for Preventing and Treating Bacterial Enteric Infections in HIV-AIDS
Preventing Bacterial Enteric Illness:
 • Antimicrobial
IDSA Recommendations ... if MIC<0.12 ug/ml ... Enteric #Bacterial #IDSA ... #Prevention #Treatment ... infections #HIVAIDS #pharmacology
IDSA - Approach to Treating a Patient With Diabetic Foot Osteomyelitis
When to consider a trial of
IDSA - Approach ... a Patient With Diabetic ... of nonsurgical treatment ... 48–72 h if on treatment ... renal failure) #Diabetic
IDSA Diabetic Foot infection - In Which Situations Is Diagnostic Bone Biopsy Most Recommended?
 • Patient
IDSA Diabetic Foot ... favor of prolonged treatment ... osteomyelitis with antibiotic-resistant ... metalware #IDSA ... #Diabetic #Foot
IDSA Recommendations for Treating Mucosal Candidiasis in HIV-AIDS
Oropharyngeal Candidiasis: Initial Episodes (Duration of Therapy: 7–14 days)
Preferred
IDSA Recommendations ... suspension 4–6 mL ... candida #mucosal #IDSA ... #Prevention #Treatment ... infections #HIVAIDS #pharmacology
IDSA Recommendations for Preventing and Managing Cryptosporidiosis in HIV-AIDS
Preventing Chronic Cryptosporidiosis:
 • Because chronic cryptosporidiosis occurs
IDSA Recommendations ... mg PO BID with food ... Cryptosporidiosis #IDSA ... #Prevention #Treatment ... infections #HIVAIDS #pharmacology
IDSA Recommendations for Preventing and Treating HHV-8 Diseases—Kaposi Sarcoma (KS), Primary Effusion Lymphoma (PEL), Multicentric Castleman’s
IDSA Recommendations ... Castleman’s Disease (MCD ... recommended for KS treatment ... #Prevention #Treatment ... infections #HIVAIDS #pharmacology
Diuretics and Agents Regulating Renal Excretion

Carbonic Anhydrase Inhibitors (Acetazolamide, Dichlorphenamide)
 • Glaucoma
 • Epilepsy
 • Altitude
Inhibitors of Na+K+2Cl ... • Nephrogenic diabetes ... nocturnal enuresis • Prevention ... Tolvaptan) • Treatment ... Diuresis #Nephrology #Pharmacology